Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Transplantation and Cellular Therapy
|
May 7, 2026
Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced Melanoma
Lilit Karapetyan, Justin Moser, Barbara T Ma, et al.
Science Immunology
|
May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8<sup>+</sup> T cell responses
Hieu Minh Ta, Dia Roy, Keman Zhang, et al.
The Journal of Experimental Medicine
|
September 9, 2015
A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis
Ling Wu, Xing Chen, Junjie Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study
Theresa Medina, Jason A Chesney, Harriet M Kluger, et al.
Journal of the American Academy of Dermatology
|
March 21, 2024
Germline cancer susceptibility in individuals with melanoma
Pauline Funchain, Ying Ni, Brandie Heald, et al.
Nature Medicine
|
October 16, 2023
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Robert L Ferris, Rom S Leidner, Christine H Chung, et al.
Future Oncology (London, England)
|
February 23, 2024
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery
John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.
Transplantation and Cellular Therapy
|
February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles
Kedar Kirtane, Michael Kalos, Rocky Billups, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors
Oliver Bechter, Carmen Loquai, Stephane Champiat, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Transplantation and Cellular Therapy
|
May 7, 2026
Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced Melanoma
Lilit Karapetyan, Justin Moser, Barbara T Ma, et al.
Science Immunology
|
May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8<sup>+</sup> T cell responses
Hieu Minh Ta, Dia Roy, Keman Zhang, et al.
The Journal of Experimental Medicine
|
September 9, 2015
A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis
Ling Wu, Xing Chen, Junjie Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study
Theresa Medina, Jason A Chesney, Harriet M Kluger, et al.
Journal of the American Academy of Dermatology
|
March 21, 2024
Germline cancer susceptibility in individuals with melanoma
Pauline Funchain, Ying Ni, Brandie Heald, et al.
Nature Medicine
|
October 16, 2023
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Robert L Ferris, Rom S Leidner, Christine H Chung, et al.
Future Oncology (London, England)
|
February 23, 2024
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery
John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.
Transplantation and Cellular Therapy
|
February 28, 2026
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles
Kedar Kirtane, Michael Kalos, Rocky Billups, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors
Oliver Bechter, Carmen Loquai, Stephane Champiat, et al.
Page
of 7